A Chlorzoxazone-folic Acid Combination Improves Cognitive Affective Decline in SCA2-58Q Mice

Overview

Journal Sci Rep

Specialty Science

Date 2023 Aug 3

PMID 37537226

Authors

Ksenia S Marinina

Ilya B Bezprozvanny

Polina A Egorova

Affiliations

Soon will be listed here.

Abstract

Spinocerebellar ataxia type 2 (SCA2) is a polyglutamine disorder caused by a pathological expansion of CAG repeats in ATXN2 gene. SCA2 is accompanied by cerebellar degeneration and progressive motor decline. Cerebellar Purkinje cells (PCs) seem to be primarily affected in this disorder. The majority of the ataxia research is focused on the motor decline observed in ataxic patients and animal models of the disease. However, recent evidence from patients and ataxic mice suggests that SCA2 can also share the symptoms of the cerebellar cognitive affective syndrome. We previously reported that SCA2-58Q PC-specific transgenic mice exhibit anxiolytic behavior, decline in spatial memory, and a depressive-like state. Here we studied the effect of the activation of the small conductance calcium-activated potassium channels (SK channels) by chlorzoxazone (CHZ) combined with the folic acid (FA) on the PC firing and also motor, cognitive and affective symptoms in SCA2-58Q mice. We realized that CHZ-FA combination improved motor and cognitive decline as well as ameliorated mood alterations in SCA2-58Q mice without affecting the firing rate of their cerebellar PCs. Our results support the idea of the combination therapy for both ataxia and non-motor symptoms in ataxic mice without affecting the firing frequency of PCs.

Citing Articles

Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome.

Ferraguto C, Piquemal-Lagoueillat M, Lemaire V, Moreau M, Trazzi S, Uguagliati B Neuropsychopharmacology. 2024; 49(13):2032-2041.

PMID: 39223257 PMC: 11480417. DOI: 10.1038/s41386-024-01956-6.

A combination of chlorzoxazone and folic acid improves recognition memory, anxiety and depression in SCA3-84Q mice.

Marinina K, Bezprozvanny I, Egorova P Hum Mol Genet. 2024; 33(16):1406-1419.

PMID: 38727562 PMC: 11305683. DOI: 10.1093/hmg/ddae079.

Memory decline, anxiety and depression in the mouse model of spinocerebellar ataxia type 3.

Marinina K, Bezprozvanny I, Egorova P Hum Mol Genet. 2023; 33(4):299-317.

PMID: 37862125 PMC: 10840381. DOI: 10.1093/hmg/ddad179.

References

Liang M, Zhou Q, Yang K, Yang X, Fang J, Chen W . Identify changes of brain regional homogeneity in bipolar disorder and unipolar depression using resting-state FMRI. PLoS One. 2013; 8(12):e79999. PMC: 3851159. DOI: 10.1371/journal.pone.0079999. View

Shakkottai V, Costa M, DellOrco J, Sankaranarayanan A, Wulff H, Paulson H . Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3. J Neurosci. 2011; 31(36):13002-14. PMC: 3170039. DOI: 10.1523/JNEUROSCI.2789-11.2011. View

Egorova P, Marinina K, Bezprozvanny I . Chronic suppression of STIM1-mediated calcium signaling in Purkinje cells rescues the cerebellar pathology in spinocerebellar ataxia type 2. Biochim Biophys Acta Mol Cell Res. 2023; 1870(5):119466. DOI: 10.1016/j.bbamcr.2023.119466. View

Huynh D, Figueroa K, Hoang N, Pulst S . Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet. 2000; 26(1):44-50. DOI: 10.1038/79162. View

Yasuhara M, Levy G . Pharmacodynamics of zoxazolamine and chlorzoxazone in rats. Pharm Res. 1988; 5(7):401-7. DOI: 10.1023/a:1015976131643. View

Valis M, Masopust J, Bazant J, Rihova Z, Kalnicka D, Urban A . Cognitive changes in spinocerebellar ataxia type 2. Neuro Endocrinol Lett. 2011; 32(3):354-9. View

Olivito G, Lupo M, Iacobacci C, Clausi S, Romano S, Masciullo M . Microstructural MRI Basis of the Cognitive Functions in Patients with Spinocerebellar Ataxia Type 2. Neuroscience. 2017; 366:44-53. DOI: 10.1016/j.neuroscience.2017.10.007. View

Bohne P, Mourabit D, Josten M, Mark M . Cognitive deficits in episodic ataxia type 2 mouse models. Hum Mol Genet. 2021; 30(19):1811-1832. PMC: 8444449. DOI: 10.1093/hmg/ddab149. View

Matschke L, Rinne S, Snutch T, Oertel W, Dolga A, Decher N . Calcium-activated SK potassium channels are key modulators of the pacemaker frequency in locus coeruleus neurons. Mol Cell Neurosci. 2018; 88:330-341. DOI: 10.1016/j.mcn.2018.03.002. View

10.

Ji H, Hougaard C, Frisch Herrik K, Strobaek D, Christophersen P, Shepard P . Tuning the excitability of midbrain dopamine neurons by modulating the Ca2+ sensitivity of SK channels. Eur J Neurosci. 2009; 29(9):1883-95. PMC: 4430859. DOI: 10.1111/j.1460-9568.2009.06735.x. View

11.

Partearroyo T, Perez-Miguelsanz J, Pena-Melian A, Maestro-de-Las-Casas C, Ubeda N, Varela-Moreiras G . Low and high dietary folic acid levels perturb postnatal cerebellar morphology in growing rats. Br J Nutr. 2016; 115(11):1967-77. DOI: 10.1017/S0007114516001008. View

12.

Eckart S, Hortnagl H, Kronenberg G, Gertz K, Horster H, Endres M . Reduced nerve growth factor levels in stress-related brain regions of folate-deficient mice. Neuroscience. 2013; 245:129-35. DOI: 10.1016/j.neuroscience.2013.04.014. View

13.

Budni J, Moretti M, Freitas A, Neis V, Ribeiro C, de Oliveira Balen G . Behavioral and neurochemical effects of folic acid in a mouse model of depression induced by TNF-α. Behav Brain Res. 2021; 414:113512. DOI: 10.1016/j.bbr.2021.113512. View

14.

Kasumu A, Bezprozvanny I . Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias. Cerebellum. 2010; 11(3):630-9. PMC: 3257360. DOI: 10.1007/s12311-010-0182-9. View

15.

Budni J, Molz S, Dal-Cim T, Martin-de-Saavedra M, Egea J, Lopez M . Folic Acid Protects Against Glutamate-Induced Excitotoxicity in Hippocampal Slices Through a Mechanism that Implicates Inhibition of GSK-3β and iNOS. Mol Neurobiol. 2017; 55(2):1580-1589. DOI: 10.1007/s12035-017-0425-6. View

16.

Walter J, Alvina K, Womack M, Chevez C, Khodakhah K . Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci. 2006; 9(3):389-97. DOI: 10.1038/nn1648. View

17.

Budni J, Zomkowski A, Engel D, Santos D, Dos Santos A, Moretti M . Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice. Exp Neurol. 2012; 240:112-21. DOI: 10.1016/j.expneurol.2012.10.024. View

18.

Gao Z, Todorov B, Barrett C, van Dorp S, Ferrari M, van den Maagdenberg A . Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice. J Neurosci. 2012; 32(44):15533-46. PMC: 6621567. DOI: 10.1523/JNEUROSCI.2454-12.2012. View

19.

Alvina K, Khodakhah K . The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J Neurosci. 2010; 30(21):7258-68. PMC: 2909847. DOI: 10.1523/JNEUROSCI.3582-09.2010. View

20.

DMello A, Crocetti D, Mostofsky S, Stoodley C . Cerebellar gray matter and lobular volumes correlate with core autism symptoms. Neuroimage Clin. 2015; 7:631-9. PMC: 4375648. DOI: 10.1016/j.nicl.2015.02.007. View